20 November 2026
Sidley Represents Starna Therapeutics in Licensing Agreement With Pfizer Valued at Up to US$2.6 Billion
Advising firms
Deal team
3 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Lila Hope Lead | Sidley | Not stated | Technology and Life Sciences Transactions | Not stated |
| Jennifer Raab Lead | Sidley | Not stated | Technology and Life Sciences Transactions | Not stated |
| Yuhan Wu | Sidley | Not stated | Technology and Life Sciences Transactions | Not stated |
Want co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 2.60bn (US$2.6 billion)
- What the figure measures
- Total transaction value
- Client
- Starna Therapeutics Co., Ltd.Other
- Counterparties
- Pfizer Inc. (Other)